Rising hospital strain is causing emergency departments to become overwhelmed, risking patient safety and hospital operations, with concerns growing among health experts.
Browsing Category
Healthcare operations
42 posts
Strength Testing In Remote Work: Improving Musculoskeletal Wellness
New remote strength assessment tools aim to detect early musculoskeletal issues among remote employees, helping employers prevent costly health problems.
Wellness Signal Monitor: Coroner Says Woman Likely Died After Measles
Pennsylvania coroner reports unvaccinated woman likely died from measles complications, highlighting ongoing public health concerns.
Roche’s Collaborator MediLink Announces Phase III Data For Tam-Peli Showing Significantly Improved Overall Survival In Chinese Patient Population With Relapsed Small-cell Lung Cancer
MediLink reports significant overall survival benefits in phase III trial of Tam-Peli for relapsed small-cell lung cancer in China, signaling potential advances.
Why Benefit Check Bots Are Vital For Modern Safety-Net Programs
Benefit check bots are emerging as vital tools for streamlining eligibility screening in safety-net programs, filling a critical capacity gap in social support systems.
Roivant To Present Topline Results From The Phase 2 PHocus Study Of Mosliciguat In Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) At The ERS Congress 2026 On Tuesday, September 8, 2026, And Host Investor Call
Roivant will present topline results from its Phase 2 PHocus study of Mosliciguat in pulmonary hypertension with ILD at the ERS Congress 2026 on September 8.
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China
HUTCHMED announces trial results showing improved progression-free survival with ORPATHYS® plus TAGRISSO® in lung cancer patients in China.
HUTCHMED Announces NMPA Approval For ATLED® (Fanregratinib) For The Treatment Of Patients With FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma
HUTCHMED’s ATLED® (Fanregratinib) gains approval from China’s NMPA for treating FGFR2-fusion intrahepatic cholangiocarcinoma, expanding options for patients.
Breaking Barriers: FDA Approves New Treatment For Advanced Pancreatic Cancer
The FDA has approved a new targeted treatment for metastatic pancreatic cancer, marking a significant step in cancer therapy. Details on effectiveness and next steps follow.
Consumer Safety And Brain Monitoring: The Emerging Trend To Watch
New developments in brain monitoring are gaining attention for consumer safety, signaling a potential shift in health and safety oversight for brands.